FINANCIAL NEWS

Dubai’s NewBridge secures $12m financing

22 Sep 2010

(MENAFN) Dubai-based NewBridge Pharmaceuticals said that it has completed its $12 million Series B financing, bringing the total amount raised to $16 million, Reuters reported.

The Series B financing round was led by Kuwait Life Sciences Company (KLSC), a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.

NewBridge is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey, and Caspian regions.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more